E Money Monday

Today, after the pileup of results last week, markets caught their breath and rose. We had good news from a Japanese favorite, bad news from a British bank we sold, and good news for a Chinese firm. Two US shares I often write about are also up on good news. The Dow is up too.

Drugs

Eisai today reported on its Q1 this year in Yen. Its revenues rose 7.5% y/y to Yen 165.583 billion and operating profits jumped 24.4% to Y32.12 million. Pretax profits were Y32.448 billion up 20.3% and net was up 12% to Y24.753. EPS was also up 12% from prior year at 85.234 Yen per share. Esally's big winners were drugs against epilepsy, insomnia, neuralgia--an indication of its focus. It also sold 91.3% more of its Aricept drug against Alzheimer's Disease which is not yet approved here, probably to desperate Japanese elders. Japanese sales were up 91.3% from prior year Q1,in its largest market. Its second largest market, America, saw sales up 115% and its third, China, 108%. It did not raise its dividend in part because its cash on hand has not risen by much. Note that all data is in GAAP.

Teva in Israel gained 2.5% on no news. Compugen rose 10.8%

Glaxo in Britain also rose in reaction to its sale of adjuvants to the developer of a potential European Union corona virus drug, French Sanofi. The duo will get money for 300 million doses. GSK gained 2.11%.

Zymeworks, recommended by Martin Ferera, rose nearly 6%. ZYME.

Even Chembio Diagnostics of Long Island rose 6.5%.

However insider Jane Huang sold %630,000 worth of Beigene which nonetheless gained 6% hitting $225.5.

Tech is no wreck

Chinese electric vehicle maker NIO reported its sales were up 332% in July to 3533 sold and the stock jumped 13% on the news.

Vodafone gained 0.6% because it is monetizing its cell towers.

Fanuc, the Japanese factory robot firm, gained 2.51% today.

Qualcomm which we own to hold an unlisted distance diagnosis stock from Israel, is up on expectations that Huawei will pay license fees to it. Sanford Bernstein brokers raised QCOM to outperform today. It was upgraded by Bernstein to outperform.

1 2
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.